1. Use of a bacterial vaccinating preparation developed from a given bacterium of the Bordetella genus for the preparation of a protective antigen for man and animals against the infections and the toxic effects caused by a bacterium of the Bordetella genus but different from that of the vaccinating preparation.
2. Use of a vaccinating preparation developed from an adenylate cyclase of a given bacterium of the Bordetella genus for the preparation of a protective antigen for man or animals against the infections and the toxic effects caused by a bacterium of the Bordetella genus different from that from which the adenylate cyclase is derived, the said adenylate cyclase being such as that obtained by placing the supernatant of a bacterial culture of Bordetella in contact with a Affigel-calmodulinR gel.
3. Use according to claim 1 or 2, characterized in that the bacteria of the Bordetella genus are selected from B.pertussis, B.parapertussis, and B.bronchiseptica.
4. Use according to claim 3, characterized in that the vaccinating preparation is developed from B.bronchiseptica or from the adenylate cyclase of B.bronchiseptica and that it is used in order to prepare a protective antigen against the infections and the toxic effects caused by B.pertussis or B.parapertussis, the said adenylate cyclase being such as that obtained by placing the supernatant of a bacterial culture of Bordetella in contact with a Affigel-calmodulinR gel.
5. Use according to claim 3, characterized in that the vaccinating preparation is developed from B.pertussis or the adenylate cyclase of B.pertussis and that it is used in order to prepare a protective antigen against the infections and the toxic effects caused by B.bronchiseptica or B.parapertussis, the said adenylate cyclase being such as that obtained by placing the supernatant of a bacterial culture of Bordetella in contact with a Affigel-calmodulinR gel.
6. Use according to claim 3, characterized in that the vaccinating preparation is developed from B.parapertussis or the adenylate cyclase of B.parapertussis and that it is used in order to prepare a protective antigen against the infections and the toxic effects caused by B.pertussis or B.bronchiseptica, the said adenylate cyclase being such as that obtained by placing the supernatant of a bacterial culture of Bordetella in contact with a Affigel-calmodulinR gel.
7. Vaccines capable of inducing protection against the toxic effects and the infections caused by the Bordetella, characterized in that they are molecular vaccines containing at least the active part of the amino acid sequence represented in the figure, where appropriate combined or not, in the same inoculum, with FHA andor PTx.
8. Use according to any one of the claims 1 to 6, characterized in that the vaccinating preparations are combined or not, in the same inoculum, with FHA andor PTx.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A system for supplying a fluid in a vehicle, comprising:
a compressed air source; a tank in fluid communication with the compressed air source, the tank configured to contain a vehicular fluid, the tank including an outlet at a bottom of a lower portion of the tank;
a dosing module in fluid communication with the tank via the outlet, the dosing module in fluid communication with a component of a vehicle that receives the vehicular fluid; and
a controller mechanism coupled to the compressed air source and the dosing module, the controller mechanism configured to:
regulate an amount of air pressure in the tank, and
control the dosing of the vehicular fluid using the dosing module,
wherein the system does not include a vehicular fluid pump such that compressed air from the compressed air source pressurizes the dosing module with the vehicular fluid.
2. The system of claim 1, wherein the vehicular fluid comprises urea.
3. The system of claim 1, wherein the compressed air source is provided by a vehicle compressed air source or an air compressor.
4. The system of claim 1, further comprising an air-oil separator in fluid communication with the compressed air source and the tank, the air-oil separator interposed between the compressed air source and the tank.
5. The system of claim 1 further comprising a relief valve in fluid communication with the tank and the dosing module, the relief valve configured to purge the vehicular fluid from a fluid line fluidly coupling the dosing module to the tank and to purge compressed air from the tank.
6. The system of claim 1, wherein the compressed air source is in fluid communication with and coupled to an upper portion of the tank, and wherein the dosing module is in fluid communication with and coupled to a lower portion of the tank.
7. The system of claim 6, wherein the tank comprises a filter coupled to the lower portion of the tank in fluid communication with the dosing module.
8. The system of claim 1, wherein the controller mechanism comprises a control module electrically coupled to the compressed air source and dosing module.
9. The system of claim 8, further comprising a manometer in fluid communication with the tank, the manometer outputting a signal to the control module indicative of a pressure within at least one of the tank or a fluid line fluidly coupling the tank and the dosing module.
10. The system of claim 8, wherein the control module is configured to cause the relief valve to purge the vehicular fluid from the fluid line and the compressed air from the tank upon a deactivation of the vehicle.
11. The system of claim 8, wherein the control module is further electrically coupled to the dosing module, and wherein the control module is configured to control dosing of the vehicular fluid to the component of the vehicle that receives the vehicular fluid.
12. A method of controlling delivery of a vehicular fluid, comprising:
pressurizing, using a control module, a tank containing the vehicular fluid using compressed air from a compressed air source, the tank including an outlet at a bottom of a lower portion of the tank; and
selectively releasing, using the control module, the vehicular fluid to a component of a vehicle via a dosing module, the dosing module fluidly coupled to the tank via the outlet,
wherein no vehicular fluid pump is in fluid communication with either the tank or the dosing module such that the compressed air from the compressed air source pressurizes the dosing module with the vehicular fluid.
13. The method of claim 12 wherein the vehicular fluid comprises urea.
14. The method of claim 13 further comprising purging, using the control module, a fluid line fluidly coupling the dosing module to the tank in response to a deactivation of the vehicle.
15. The method of claim 14 further comprising purging, using the control module, compressed air from the tank in response to the deactivation of the vehicle.
16. A reductant delivery system for supplying a fluid for a selective catalytic reduction system of a vehicle having an engine that produces an exhaust gas containing nitrogen oxide, the reductant delivery system consisting essentially of:
a compressed air source;
a tank in fluid communication with the compressed air source, the tank configured to contain a diesel exhaust fluid, the tank including an outlet at a bottom of a lower portion of the tank;
a dosing module in fluid communication with the tank via the outlet, the dosing module in fluid communication with a component of a vehicle that receives the diesel exhaust fluid;
a relief valve in fluid communication with the tank and the dosing module, the relief valve configured to purge compressed air from the tank in response to a deactivation of the vehicle; and
a controller mechanism coupled to the compressed air source, the controller mechanism configured to regulate an amount of air pressure in the tank.
17. The reductant delivery system of claim 16, wherein the diesel exhaust fluid comprises urea.
18. The reductant delivery system of claim 16, wherein the system does not include a vehicular fluid pump in fluid communication with the dosing module and the tank.
19. The reductant delivery system of claim 16 further consisting essentially of:
a manometer in fluid communication with the tank, the manometer outputting a signal to the controller mechanism indicative of a pressure within at least one of the tank or a fluid line fluidly coupling the tank and the dosing module; and
an air-oil separator in fluid communication with the compressed air source and the tank, the air-oil separator interposed between the compressed air source and the tank.
20. The reductant delivery system of claim 16, wherein the controller mechanism comprises a control module electrically coupled to the compressed air source, the control module configured to regulate an amount of air pressure in the tank.